EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudie

Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves

Stefano Cannata, Ibrahim Sultan, Nicolas Van Mieghem, Arturo Giordano, Ole De Backer, Johnathan Byrne, Didier Tchetche, Sergio Buccheri, Luis Nombela-Franco, Rui Campante Teles, Marco Barbanti, Emanuele Barbato und 28 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.03.015 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Stefano Cannata und 39 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Interventional Cardiology, Department of Cardiothoracic Surgery, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Speci…. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement, Aortic Valve, Aortic Valve Stenosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: No comparative data exist with the self-expanding Navitor (NAV) and the balloon-expandable SAPIEN 3 Ultra (ULTRA) transcatheter heart valves (THVs). OBJECTIVES: This study sought to investigate the 1-year outcomes of transcatheter aortic valve replacement using the intra-annular NAV and the ULTRA THVs. METHODS: The NAVULTRA (Navitor and SAPIEN 3 Ultra) registry included consecutive patients who underwent transfemoral transcatheter aortic valve replacement at 16 centers with NAV or ULTRA between November 2018 and April 2024. Propensity score matching was used for adjustment. The primary outcomes of interest were all-cause death and the composite of all-cause death, disabling stroke, and hospitalization for heart failure at 1 year. RESULTS: The overall study cohort included 3,878 patients treated with NAV (n = 1,746) or ULTRA (n = 2,176). The propensity score-matched population resulted in 1,363 pairs. At 1 year, the rate of death from any cause was 9.7% with NAV and 9.9% with ULTRA (adjusted P = 0.585). Similarly, there were no significant differences in primary composite outcome (13.6% in the NAV group and 12.6% in the ULTRA group; adjusted P = 0.218). The rate of new permanent pacemaker implantation (20.6% vs 10.6%; adjusted P < 0.01) and heart failure rehospitalization (4.6% vs 2.8%; adjusted P < 0.05) was higher in NAV group. At 1 year, the use of NAV was associated with higher rates of mild paravalvular leak (OR: 1.53; 95% CI: 1.01 to 2.33; adjusted P < 0.05) but lower mean transprosthetic gradients compared with ULTRA (mean change:-3.90, 95% CI: -4.47 to -3.34; adjusted P < 0.01). CONCLUSIONS: Both intra-annular THVs were associated with similar 1-year clinical outcomes; however, differences were observed in secondary clinical endpoints and valve hemodynamic performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisTranscatheter Aortic Valve ReplacementAortic ValveAortic Valve StenosisBalloon ValvuloplastyHumansMaleRegistriesFemaleTreatment OutcomeAged, 80 and overAgedTime FactorsProsthesis DesignRisk FactorsRisk AssessmentRecovery of FunctionRetrospective StudiesHemodynamicsHeart Failure

Stichwörter der Autor:innen

NavitorSAPIEN 3 UltraTAVRintra-annular

Autor:innen und Institutionen

  • Unit of Interventional Cardiology, Department of Cardiothoracic Surgery, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), Palermo, Italy; Cardiovascular Research Institute M…
  • Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, the Netherlands.
  • Invasive Cardiology Unit, Pineta Grande Hospital, Castel Volturno, Caserta, Italy.
  • Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • King's College Hospital NHS Foundation Trust, London, United Kingdom.

Zitieren

APA

Cannata, S., Sultan, I., Van Mieghem, N., Giordano, A., De Backer, O., Byrne, J., Tchetche, D., Buccheri, S., Nombela-Franco, L., Teles, R. C., Barbanti, M., Barbato, E., Amat Santos, I., Blackman, D. J., Maisano, F., Lorusso, R., La Spina, K., Millin, A., Kliner, D. E., …, & Latib, A. (2025). Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.03.015

Vancouver

Cannata S, Sultan I, Van Mieghem N, Giordano A, De Backer O, Byrne J, et al. Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.03.015

BibTeX
@article{Cannata2025,
  author = {Cannata, Stefano and Sultan, Ibrahim and Van Mieghem, Nicolas and Giordano, Arturo and De Backer, Ole and Byrne, Johnathan and Tchetche, Didier and Buccheri, Sergio and Nombela-Franco, Luis and Teles, Rui Campante and Barbanti, Marco and Barbato, Emanuele and Amat Santos, Ignacio and Blackman, Daniel J and Maisano, Francesco and Lorusso, Roberto and La Spina, Ketty and Millin, Antonella and Kliner, Dustin E and van den Dorpel, Mark and Acerbi, Elena and Lulic, Davorka and Divekar, Kaivalya and Cesario, Vincenzo and Chavez Solsol, Jorge Francisco and Brito, Joao and Costa, Giuliano and Casenghi, Matteo and Fernandez Cordon, Clara and Sherwen, Amanda and Buzzatti, Nicola and Pasta, Salvatore and Turrisi, Marco and Minacori, Michele and Manca, Paolo and Nuzzi, Vincenzo and Tamburino, Corrado and Bedogni, Francesco and Gandolfo, Caterina and Latib, Azeem},
  title = {Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.03.015}
}
Kostenlos starten →